Morgan Stanley

Morgan Stanley’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Morgan Stanley’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell
2019 Q4	$6K	Buy
2019 Q3	$14K	Sell
2019 Q2	$72K	Buy
2019 Q1	$21K	Sell
2018 Q4	$51K	Sell
2018 Q3	$550K	Buy
2018 Q2	$428K	Sell
2018 Q1	$527K	Buy
2017 Q4	$675K	Buy